Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice

European Journal of Neuroscience

Volumn 19, Issue 10, 2004, Pages 2703-2710

  Hellström Lindahl, Ewa ^a   Court, Jennifer ^b   Keverne, Jessica ^b   Svedberg, Marie ^a   Lee, Mandy ^b   Marutle, Amelia ^a   Thomas, Alan ^b   Perry, Elaine ^b   Bednar, Ivan ^a   Nordberg, Agneta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Neurotrophins; Nicotinic 7 receptors; Sapp; Secretases

Indexed keywords

ALPHA BUNGAROTOXIN; AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; MECAMYLAMINE; NERVE GROWTH FACTOR; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN BLOOD VESSEL; BRAIN HOMOGENATE; DRUG EFFECT; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE;

AGE FACTORS; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; BLOOD VESSELS; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; BUNGAROTOXINS; CELL LINE, TUMOR; CEREBRAL ARTERIES; DRUG ADMINISTRATION SCHEDULE; EMBRYO; ENDOPEPTIDASES; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE ISOTOPES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOSACCHARIDE TRANSPORT PROTEINS; NERVE GROWTH FACTOR; NEUROBLASTOMA; NICOTINE; PEPTIDE FRAGMENTS;

EID: 2942598335     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-816X.2004.03377.x     Document Type: Article

References (52)

1. Abbas, N., Bednar, I., Mix, E., Svedberg, M., Paterson, D., Ljungberg, A., Morris, C., Winblad, B., Nordberg, A. & Zhu, J. (2002) Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPswe transgenic mice. J. Neuroimmunol., 126, 50-57.
2. Beach, T.G., Kuo, Y., Schwab, C., Walker, D.G. & Roher, A.E. (2001) Reduction of the cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine. Neurosci. Lett., 310, 21-24.
3. swe transgenic mice. Mol. Cell. Neurosci., 20, 354-365.
4. Boncristiano, S., Calhoun, M.E., Kelly, PH., Bondolfi, L., Stadler, M., Phinney, A.L., Abramowski, D., Sturchler-Pierrat, C., Enz, A., Sommer, B., Staufenbiel, M. & Jucker, M. (2002) Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J. Neurosci., 22, 3234-3243.
5. Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N. & Cattaneo, A. (2000) Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. USA, 97, 6826-6831.
6. Check, E. (2002) Nerve inflammation halts trial for Alzheimer's drug. Nature, 415, 462.
7. Cotter, D.S., Wilson, S., Roberts, E., Kerwin, R. & Everall, I.P. (2000) Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophrenia Res., 41, 313-323.
8. Dineley, K.T., Bell, K.A., Bui, D. & Sweatt, J.D. (2002) β-amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Biol. Chem., 277, 25056-25061.
9. Dineley, K.T., Westerman, M., Bui, D., Bell, K., Ashe, K.H. & Sweatt, J.D. (2001) Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci., 21, 4125-4133.
10. Dominguez, D.I. & De Strooper, B. (2002) Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease. Trends Pharmacol. Sci., 23, 324-330.
11. Evin, G. & Weidemann, A. (2002) Biogenesis and metabolism of Alzheimer's disease Aβ amyloid peptides. Peptides, 23, 1285-1297.
12. French, S.J., Humby, T., Horner, C.H., Sofroniew, M.V., Rattray, M., Flores, C.M., Rogers, S.W., Pabreza, L., Wolf, B. & Kellar, K.J. (1999) Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine. Mol. Brain Res., 67, 124-136.
13. Fukumoto, H., Cheung, B.S., Hyman, B.T. & Irizarry, M.C. (2002) β-secretase protein and activity are increased in the neocortex in Alzheimer's disease. Arch. Neurol., 59, 1381-1389.
14. Ge, Y.W. & Lahiri, D.K. (2002) Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease. Ann. NY Acad. Sci., 973, 463-467.
15. Hardy, J. & Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road of therapeutics. Science, 297, 353-356.
16. Holsinger, R.M., McLean, C.A., Beyreuther, K., Masters, C.L. & Evin, G. (2002) Increased expression of amyloid precursor β-secretase in Alzheimer's disease. Ann. Neurol., 51, 783-786.
17. Holtzman, D.M., Pagan, A.M., Mackey, B., Tenkova, T., Sartorius, L., Paul, S.M., Bales, K., Ashe, K.H., Irizarry, M.C. & Hyman, B.T. (2000) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol., 47, 739-747.
18. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. & Cole, G. (1996) Correlative memory deficits, Abeta elevation and amyloid plaques in transgenic mice. Science, 274, 99-102.
19. Irizarry, M.C., Locascio, J.J. & Hyman, B.T. (2001) β-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging. Am. J. Pathol., 158, 173-177.
20. Irizarry, M.C., McNamara, M., Fedorchak, K., Hsiao, K. & Hyman, B.T. (1997) APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol., 56, 965-973.
21. Janus, C., Pearson, J., McLaurin, J., Mathews, P.M., Jiang, Y., Schmidt, S.D., Christhi, M.A., Horne, P., Heslin, D., French, J., Mount, H.T., Nixon, R.A., Mercken, M., Bergeron, C., Fraser, P.E., St George-Hyslop, P. & Westaway, D. (2000) Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature, 408, 979-982.
22. Jonnala, R.R., Tery, A.V. & Buccafusco, J.J. (2002) Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. Life Sci., 70, 1543-1554.
23. Kenny, P.J., File, S.E. & Rattray, M. (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain derived neurotrophic factor mRNA in rat hippocampus. Mol. Brain Res., 85. 234-238.
24. Kim, S.H., Kim, Y.K., Jeong, S.J., Haass, C., Kim, Y.H. & Sun, Y.H. (1997) Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine. Mol. Pharmacol., 52, 430-436.
25. Lee, M., Martin-Ruiz, C., Graham, A., Court, J., Jaros, E., Perry, R., Iverson, P., Bauman, M. & Perry, E. (2002) Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain, 125, 1483-1495.
26. Liu, Q.-S., Kawai, H. & Berg, D.K. (2001) β-amyloid peptide bocks the response of α7-containing nicotinic receptors on hippocampal neurons. Proc. Natl. Acad. Sci. USA, 98, 4735-4739.
27. Lowry, O.H., Rosebrough, N.J., Fair, A.L. & Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
28. Marutle, A., Zhang, X., Court, J., Piggott, M., Johnson, M., Perry, R., Perry, E. & Nordberg, A. (2001) Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J. Chem. Neuroanatomy, 22, 115-126.
29. Matsuoka, Y., Saito, M., LaFrancois, J., Saito, M., Gaynor, K., Olm, V., Wang, L., Casey, E., Lu, Y., Shiratori, C., Lemere, C. & Duff, K. (2003) Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to β-amyloid. J. Neurosci., 23, 29-33.
30. Morgan, D., Diamond, D.M., Gottschall, P.E., Ugen, K.E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., Connor, K., Hacher, J., Hope, C., Gordon, M. & Arendash, G.W. (2000) Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature, 408, 982-985.
31. Mouton, P.R. (2002) Principles and Practices of Unbiased Stereology. The Johns Hopkins University Press, Baltimore, Maryland.
32. Nagele, R.G., D'Andrea, M.R., Anderson, W.J. & Wang, H.Y. (2002) Intracellular accumulation of β-amyloid 1-42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer disease. Neuroscience, 110, 199-211.
33. Nicoll, J.A.R., Wilkinson, D., Holmes, C., Steart, P., Markham, H. & Weller, R.O. (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med., 9, 448-452.
34. Nordberg, A., Hellström-Lindahl, E., Lee, M., Johnson, M., Mousavi, M., Hall, R., Perry, E., Bednar, I. & Court, J. (2002) Chronic nicotine treatment reduces β-amyloidosis in the brain of a mouse model of Alzheimerës disease (APPsw). J. Neurochem., 81, 655-658.
35. Ono, K., Hasegawa, K., Yamada, M. & Naiki, H. (2002) Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro. Biol. Psychiatry, 52, 880-886.
36. Paxinos, G. & Frankin, K.B.J. (2001) The Mouse Brain. Academic Press, London.
37. Permanne, E., Adessi, C., Saborio, G.P., Fraga, S., Frossard, J., van Dorpe, J., Dewachter, I., Banks, W.A., van Leuven, F. & Soto, C. (2002) Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a β-sheet breaker peptide. FASEB J., 16, 860-862.
38. Pfeifer, M., Boncristiano, S., Bondolfi, L., Stadler, A., Deller, T., Staufenbiel, M., Mathews, P.M. & Jucker, M. (2002) Cerebral hemorrhage after passive anti-Aβ immunotherapy. Science, 298, 139.
39. Rossner, S., Apelt, J., Schliebs, R., Perez-Polo, J.R. & Bigl, V. (2001) Neuronal and glial β-secretase (BACE) protein expression in transgenic Tg 2576 mice with amyloid plaque pathology. J. Neurosci. Res., 64, 437-446.
40. Rowell, P. & Duggan, D. (1998) Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine. Neuropharmacology, 37, 103-111.
41. Ruiz-Leon, Y. & Pascual, A. (2001) Brain-derived neurotrophic factor stimulates beta-amyloid gene promoter activity by a Ras-dependent/AP-1- independent mechanism in SH-SY5Y neuroblastoma cells. J. Neurochem., 79, 278-285.
42. Salomon, A.R., Marcinowski, K.J., Friedland, R.P. & Zagorski, M.G. (1996) Nicotine inhibits amyloid formation by the β-peptide. Biochemistry, 35, 13568-13578.
43. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D. & Seubert, P. (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400, 173-177.
44. Shie, F.-S., LeBoeur, R.C. & Jin, L.-W. (2003) Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice. Neuroreport, 14, 123-129.
45. Steinberg, D. (2002) Companies halt first Alzheimer vaccine trial. Scientist, 16, 22.
46. Tyler, SJ., Dawbarn, D., Wilcock, G.K. & Allen, S.J. (2002) α- and β-secretase: profound changes in Alzheimer's disease. Biochem. Biophys. Res. Commun., 299, 373-376.
47. Utsuki, T., Shoaib, M., Holloway, H.W., Ingram, D.K., Wallace, W.C., Haroutunian, V., Sambamutti, K., Lahiri, D.K. & Greig, N.H. (2002) Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat. J. Alzheimers Dis., 4, 405-415.
48. Wang, H., Yu, M., Ochani, M., Amelia, C.A., Tanovic, M., Susarla, S., Li, J.H., Wang, H., Yang, H., Ulloa, L., Al-Abed, Y., Czura, C.J. & Tracey, K.J. (2003) Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature, 421, 384-387.
49. Wang, H.Y., Lee, D.H.S., Davis, C.B. & Shank, R.P. (2000) Amyloid peptide Aβ (1-42) binds selectively and with picomolar affinity to α7 nicotine acetylcholine receptors. J. Neurochem., 75, 1155-1161.
50. Weggen, S., Eriksen, J., Das, P., Sagi, S.A., Wang, R., Pietrizik, C.U., Findlay, K.A., Smith, T.E., Murphy, M.P., Bulter, T., Kang, D.E., Marquez-Sterling, N., Golde, T.E. & Koo, E.H. (2001) A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature, 414, 212-216.
51. Wolfe, M.S. (2002) Therapeutic strategies for Alzheimer's disease. Nature Rev. Drug Discovery, 1, 859-866.
52. Wyss-Coray, T., Loike, J.D., Brionne, T.C., Lu, E., Anankov, R., Yan, F., Silverstein, S.C. & Huseman, J. (2003) Adult mouse astrocytes degrade amyloid β in vitro and in situ. Nat. Med., 9, 453-457.